Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System USP, 0.014 mg/day. The approved product which is to be used weekly is the generic version of Menostar Transdermal System and is approved for preventing postmenopausal osteoporosis. Zydus Lifesciences will manufacture the drug at its formulation manufacturing […]
Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo Inc. for commercializing a couple of its pipeline biosimilar assets — bDenosumab and bUstekinumab in Japan. Ustekinumab is a biosimilar of the reference drug Stelara, which is a monoclonal antibody for the treatment of psoriasis, ulcerative colitis, […]
Haoma Medica has wrapped up a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as an oral treatment for osteoporosis. The UK-based biotech company initiated the human trial of NaQuinate last year in healthy adults for assessing its single and multiple doses. The primary goal of the trial was to evaluate […]
Bones are constantly broken down to develop new bones and a balance should be maintained between these two processes as if more bone is lost than what is being created ,it may result in osteoporosis. Below given are few ways to strengthen bones Milk Dairy products are a rich source of calcium which is quintessential […]
Amgen, in collaboration with UCB, has announced the resubmission of the biologics license application (BLA) for their osteoporosis drug candidate, EVENITY (romosozumab), to the US Food and Drug Administration (FDA). This resubmission is targeted at the treatment of osteoporosis in postmenopausal women who are at high risk of fractures, marking a significant development in the […]